SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001140361-21-040670
Filing Date
2021-12-07
Accepted
2021-12-07 16:30:32
Documents
12
Period of Report
2021-12-01
Items
Item 4.02: Non-Reliance on Previously Issued Financial Statements or a Related Audit Report or Completed Interim Review

Document Format Files

Seq Description Document Type Size
1 8-K brhc10031423_8k.htm   iXBRL 8-K 36264
  Complete submission text file 0001140361-21-040670.txt   177622

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA aryd-20211201.xsd EX-101.SCH 3941
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE aryd-20211201_lab.xml EX-101.LAB 23288
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE aryd-20211201_pre.xml EX-101.PRE 16562
5 EXTRACTED XBRL INSTANCE DOCUMENT brhc10031423_8k_htm.xml XML 4251
Mailing Address 51 ASTOR PLACE, 10TH FLOOR NEW YORK NY 10003
Business Address 51 ASTOR PLACE, 10TH FLOOR NEW YORK NY 10003 212-284-2300
ARYA Sciences Acquisition Corp IV (Filer) CIK: 0001838821 (see all company filings)

IRS No.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40122 | Film No.: 211476370
SIC: 2836 Biological Products, (No Diagnostic Substances)